Ipca Laboratories Limited

NSEI:IPCALAB Rapport sur les actions

Capitalisation boursière : ₹403.7b

Ipca Laboratories Bilan de santé

Santé financière contrôle des critères 5/6

Ipca Laboratories possède un total de capitaux propres de ₹81.2B et une dette totale de ₹11.6B, ce qui porte son ratio d'endettement à 14.2%. Son actif total et son passif total sont ₹114.2B et de ₹33.1B. L'EBIT de Ipca Laboratories est ₹10.6B ce qui fait que son ratio de couverture des intérêts 23.3. Elle dispose de liquidités et de placements à court terme de ₹9.0B.

Informations clés

14.2%

Ratio d'endettement

₹11.56b

Dette

Ratio de couverture des intérêts23.3x
Argent liquide₹9.03b
Fonds propres₹81.18b
Total du passif₹33.06b
Total des actifs₹114.24b

Mises à jour récentes de la santé financière

Recent updates

Ipca Laboratories (NSE:IPCALAB) Is Paying Out A Dividend Of ₹2.00

Nov 17
Ipca Laboratories (NSE:IPCALAB) Is Paying Out A Dividend Of ₹2.00

Earnings Tell The Story For Ipca Laboratories Limited (NSE:IPCALAB)

Sep 10
Earnings Tell The Story For Ipca Laboratories Limited (NSE:IPCALAB)

Ipca Laboratories' (NSE:IPCALAB) Solid Earnings Have Been Accounted For Conservatively

Jun 07
Ipca Laboratories' (NSE:IPCALAB) Solid Earnings Have Been Accounted For Conservatively

Ipca Laboratories Limited (NSE:IPCALAB) Not Lagging Market On Growth Or Pricing

May 24
Ipca Laboratories Limited (NSE:IPCALAB) Not Lagging Market On Growth Or Pricing

Investors Interested In Ipca Laboratories Limited's (NSE:IPCALAB) Earnings

Feb 07
Investors Interested In Ipca Laboratories Limited's (NSE:IPCALAB) Earnings

Here's Why Ipca Laboratories (NSE:IPCALAB) Can Manage Its Debt Responsibly

Jan 09
Here's Why Ipca Laboratories (NSE:IPCALAB) Can Manage Its Debt Responsibly

Is Ipca Laboratories (NSE:IPCALAB) A Risky Investment?

Aug 20
Is Ipca Laboratories (NSE:IPCALAB) A Risky Investment?

Ipca Laboratories (NSE:IPCALAB) Has A Pretty Healthy Balance Sheet

Feb 28
Ipca Laboratories (NSE:IPCALAB) Has A Pretty Healthy Balance Sheet

Here's Why Ipca Laboratories (NSE:IPCALAB) Can Manage Its Debt Responsibly

Sep 20
Here's Why Ipca Laboratories (NSE:IPCALAB) Can Manage Its Debt Responsibly

Estimating The Intrinsic Value Of Ipca Laboratories Limited (NSE:IPCALAB)

Aug 31
Estimating The Intrinsic Value Of Ipca Laboratories Limited (NSE:IPCALAB)

Is Ipca Laboratories (NSE:IPCALAB) A Risky Investment?

Jun 22
Is Ipca Laboratories (NSE:IPCALAB) A Risky Investment?

Calculating The Fair Value Of Ipca Laboratories Limited (NSE:IPCALAB)

May 28
Calculating The Fair Value Of Ipca Laboratories Limited (NSE:IPCALAB)

Does Ipca Laboratories (NSE:IPCALAB) Have A Healthy Balance Sheet?

Mar 15
Does Ipca Laboratories (NSE:IPCALAB) Have A Healthy Balance Sheet?

These 4 Measures Indicate That Ipca Laboratories (NSE:IPCALAB) Is Using Debt Reasonably Well

Sep 20
These 4 Measures Indicate That Ipca Laboratories (NSE:IPCALAB) Is Using Debt Reasonably Well

Is Now The Time To Put Ipca Laboratories (NSE:IPCALAB) On Your Watchlist?

Aug 09
Is Now The Time To Put Ipca Laboratories (NSE:IPCALAB) On Your Watchlist?

Does Ipca Laboratories (NSE:IPCALAB) Have A Healthy Balance Sheet?

Jun 08
Does Ipca Laboratories (NSE:IPCALAB) Have A Healthy Balance Sheet?

How Does Ipca Laboratories Limited (NSE:IPCALAB) Stand Up To These Simple Dividend Safety Checks?

Mar 26
How Does Ipca Laboratories Limited (NSE:IPCALAB) Stand Up To These Simple Dividend Safety Checks?

Do Ipca Laboratories's (NSE:IPCALAB) Earnings Warrant Your Attention?

Mar 13
Do Ipca Laboratories's (NSE:IPCALAB) Earnings Warrant Your Attention?

Trade Alert: The Compliance Officer Of Ipca Laboratories Limited (NSE:IPCALAB), Harish Kamath, Has Sold Some Shares Recently

Feb 28
Trade Alert: The Compliance Officer Of Ipca Laboratories Limited (NSE:IPCALAB), Harish Kamath, Has Sold Some Shares Recently

Ipca Laboratories Limited's (NSE:IPCALAB) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Feb 23
Ipca Laboratories Limited's (NSE:IPCALAB) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Does Ipca Laboratories' (NSE:IPCALAB) CEO Salary Compare Well With Industry Peers?

Feb 11
Does Ipca Laboratories' (NSE:IPCALAB) CEO Salary Compare Well With Industry Peers?

Could The Ipca Laboratories Limited (NSE:IPCALAB) Ownership Structure Tell Us Something Useful?

Jan 30
Could The Ipca Laboratories Limited (NSE:IPCALAB) Ownership Structure Tell Us Something Useful?

The Ipca Laboratories (NSE:IPCALAB) Share Price Is Up 264% And Shareholders Are Boasting About It

Jan 15
The Ipca Laboratories (NSE:IPCALAB) Share Price Is Up 264% And Shareholders Are Boasting About It

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de IPCALAB ( ₹56.8B ) dépassent ses passifs à court terme ( ₹24.0B ).

Passif à long terme: Les actifs à court terme de IPCALAB ( ₹56.8B ) dépassent ses passifs à long terme ( ₹9.1B ).


Historique et analyse du ratio d'endettement

Niveau d'endettement: Le ratio dette nette/capitaux propres de IPCALAB ( 3.1% ) est considéré comme satisfaisant.

Réduire la dette: Le ratio d'endettement de IPCALAB est passé de 3.6% à 14.2% au cours des 5 dernières années.

Couverture de la dette: La dette de IPCALAB est bien couverte par le flux de trésorerie opérationnel ( 124.6% ).

Couverture des intérêts: Les paiements d'intérêts de IPCALAB sur sa dette sont bien couverts par l'EBIT ( 23.3 x couverture).


Bilan


Découvrir des entreprises saines